Overview

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Status:
Unknown status
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is ascertain the efficacy and safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% in the treatment of Acne and Post Inflammatory Hyperpigmentation in patients with skin of color.
Phase:
Phase 4
Details
Lead Sponsor:
Callender Center for Clinical Research
Collaborator:
Society Hill Dermatology
Treatments:
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Tretinoin